Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease

Caspian Journal of Internal Medicine

Volumn 7, Issue 2, 2016, Pages 88-92

  Moslemnezhad, Ameneh ^a   Mahjoub, Soleiman ^a   Moghadasi, Mehdi ^b  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Mehr Avaran Shomal Nursing Home   (Iran)

Author keywords

8 OHdG; Alzheimer's disease; DNA damage; Oxidative stress; TAC

Indexed keywords

8 HYDROXYDEOXYGUANOSINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLIC PARAMETERS; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEIVER OPERATING CHARACTERISTIC; TOTAL ANTIOXIDANT CAPACITY;

EID: 84963795101     PISSN: 20086164     EISSN: 20086172     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adh Migr 2009; 3: 88-93.
2. Akhondzadeh S, Noroozian M, Mohammadi M, et al. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 2003; 28: 53-9.
3. Kenche VB, Barnham KJ. Alzheimer's disease&metals: therapeutic opportunities. Br J Pharmacol 2011; 163: 211-9.
4. Mecocci P, Polidori MC, Cherubini A, et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol 2002; 59: 794-8.
5. Persson T, Popescu BO, Cedazo-Minguez A. Oxidative stress in Alzheimer's disease: Why did antioxidant therapy fail? Oxid Med Cell Longev 2014; 2014: 427318.
6. Butterfield DA, Reed T, Newman SF, Sultana R. Roles of amyloid ß-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 2007; 43: 658-77.
7. Mahjoub S, Masrour Roudsari. Role of oxidative stress in pathogenesis of metabolic syndrome. Caspian J Intern Med 2012, 3: 386-96.
8. Dabidi RV, Hosseinzadeh S, Mahjoub S, Hosseinzadeh M, Myers J. Endurance exercise training and diferuloyl methane supplement: changes in neurotrophic factor and oxidative stress induced by lead in rat brain. Biol Sport 2013; 30: 41-6.
9. Hosseinzadeh S, Roshan VD, Mahjoub S. Continuous exercise training and curcumin attenuate changes in brain-derived neurotrophic factor and oxidative stress induced by lead acetate in the hippocampus of male rats. Pharm Biol 2013; 51: 240-5.
10. Shahandeh M, Roshan VD, Hosseinzadeh S, Mahjoub S, Sarkisian V. Chronic exercise training versus acute endurance exercise in reducing neurotoxicity in rats exposed to lead acetate. Neural Regen Res 2013; 8: 714-22.
11. Benzie IF, Strain J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996; 239: 70-6.
12. Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45. 1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76: 365-74.
13. Mecocci P, Polidori M, Ingegni T, et al. Oxidative damage to DNA in lymphocytes from AD patients. Neurology 1998; 51: 1014-7.
14. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994; 36: 747-51.
15. Cristalli DO, Arnal N, Marra FA, de Alaniz MJ, Marra CA. Peripheral markers in neurodegenerative patients and their first-degree relatives. J Neurol Sci 2012; 314: 48-56.
16. Aldred S, Bennett S, Mecocci P. Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease. Clin Biochem 2010; 43: 267-71.
17. Sekler A, Jiménez JM, Rojo L, et al. Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism. Neuropsychiatr Dis Treat 2008; 4: 715-22.
18. Zafrilla P, Mulero J, Xandri J, et al. Oxidative stress in Alzheimer patients in different stages of the disease. Curr Med Chemistry. 2006; 13: 1075-83.
19. Pulido R, Jiménez-Escrig A, Orensanz L, Saura-Calixto F. Study of plasma antioxidant status in Alzheimer's disease. Eur J Neurol 2005; 12: 531-5.
20. Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell SR. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia. Int J Geriatr Psychiatry 1998; 13: 840-5.